ºÚÁÏÍø

ISSN: 2167-065X

Clinical Pharmacology & Biopharmaceutics
ºÚÁÏÍø

Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ ºÚÁÏÍø Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

ºÚÁÏÍø Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Citations : 1089

Indexed In
  • CAS Source Index (CASSI)
  • Index Copernicus
  • Google Scholar
  • Sherpa Romeo
  • Genamics JournalSeek
  • RefSeek
  • Hamdard University
  • EBSCO A-Z
  • OCLC- WorldCat
  • Publons
  • Euro Pub
  • ICMJE
Share This Page

Structure� and ligand�guided screening of LptA inhibitors: An initial study for developing novel Neisserial antibacterials

Joint Event on 4th European Biopharma Congress & 6th International Conference and Exhibition on Pharmacology and Ethnopharmacology

Abi Sofyan Ghifari

University of Western Australia, Australia

Posters & Accepted Abstracts: Clin Pharmacol Biopharm

DOI:

Abstract
Pathogenic Gram-negative bacteria such as Neisseria meningitidis and Neisseria gonorrhoeae have developed resistance against antibiotics due to their ability in creating an envelope on the outer layer of lipooligosaccharides (LOS). The cationic phosphoethanolamine (PEA) decoration of LOSâ�� lipid A is regulated by lipid Aâ��PEA transferase A (LptA) which may serve as a prominent target for developing new antibiotics. The discovery of Neisserial LptA has provided a structural aspect to its catalytic mechanisms and ligand recognition that are crucial for inhibitor development. A combination of structureâ�� and ligandâ��based approach has been employed to explore novel potent LptA inhibitors among millions of commercially-available compounds and approved drugs. A total of 4000 hit molecules obtained from LIDAEUS structureâ��based screening and PubMed ligand similarity search were further examined through semi-flexible docking simulation performed in MOE and Schr�¶dingerâ��s Glide. Best hits were therefore carefully selected based on their docking score, drug likeness, and pharmacological properties. Free energy of binding calculation and ligand interaction analysis suggest that the selected 20 hit compounds have a stronger binding affinity than LptA natural substrate and possess a more effective interaction with catalyticallyâ��essential residues. Further molecular dynamics (MD) simulation of these 20 compounds also confirms that they all maintained stable complex conformation showing low total RMSD, capability to maintain interactions with active site, and acceptable Ramachandran plot. This study provides an insight to drug repurposing which may serve as an initial step to develop novel potent LptA inhibitors to combat the virulence of multi-drug resistant Neisseria.
Biography
International Conferences 2025-26
 
Meet Inspiring Speakers and Experts at our 3000+ Global

Conferences by Country

Medical & Clinical Conferences

Conferences By Subject

Top